Amylyx Pharmaceuticals, Inc. (AMLX) stock
AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$26.62−0.90 (-3.27%)
Close on Nov 18, 2026Market cap $2.97BP/E –Yield –
Amylyx Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Amylyx Pharmaceuticals's price to sales ratio was 1.3× on Jan 31, 2025, against 3.7× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 1.3× | −0.0 |
| 2024 | Dec 31, 2024 | 1.3× | −2.1 |
| 2023 | Dec 29, 2023 | 3.4× | −218.3 |
| 2022 | Apr 29, 2022 | 221.7× | – |
See a number that looks wrong?